Ultima-Selank 5mg

Manufacturer Ultima Pharmaceuticals - USA
Warehouse USA Warehouse 5
Substance Selank

For security reasons, our products are shipped without brand labels. The recent boom in biotechnology has opened doors to innovative biologically-active substances, including cognitive enhancers known as nootropics.

One standout compound in this realm is Selank, previously known as "TP-7." This synthetic peptide is a carefully engineered protein, touted for its potential anti-anxiety properties and ability to enhance learning and boost energy levels?all without the risk of side effects or addiction.

Selank, a compact molecule significantly smaller than most naturally occurring proteins, was developed at the Institute of Molecular Genetics (Russian Academy of Sciences) in collaboration with the V.V. Zakusov Research Institute of Pharmacology. Alongside its counterpart, Semax, Selank was created by combining a peptide sequence called tuftsin with another sequence that enhances its stability. Tuftsin is a natural component of the body, part of the IgG antibody.

Research indicates that both tuftsin and Selank can reduce anxiety and elevate serotonin levels in animal studies, with Selank demonstrating a greater efficacy.

In Russia, Selank is approved for treating generalized anxiety disorder (GAD) and is recognized as a nootropic. While it hasn't received FDA approval for any conditions in the U.S., Selank remains available in various countries, often marketed as a dietary supplement.

How Selank Works

While the exact mechanisms of Selank are still being studied, it's believed to help stabilize enkephalins in the bloodstream?natural peptides that may help alleviate stress. However, a study in mice did not confirm the stabilization of enkephalins post-administration, leading to questions about its anti-anxiety benefits.

Some cellular research suggests that Selank may interact with GABA receptors, which are commonly associated with sedative effects. One study found that Selank increased activity in GABA-dependent inhibitory neurons, aligning with its potential sedative properties.

Additionally, Selank has been noted to enhance BDNF levels, a key neurotropic factor linked to learning and memory, possibly contributing to its cognitive benefits. It also appears to influence levels of neurotransmitters like norepinephrine, dopamine, and serotonin, which are vital for motivation, focus, and pleasure.

In an animal study, Selank was shown to increase norepinephrine but decrease dopamine and serotonin levels. In other instances, it elevated both norepinephrine and dopamine while leaving serotonin unchanged, highlighting the need for further investigation into its specific effects and mechanisms.

Potential Benefits

A preliminary clinical trial with 62 participants found that those taking Selank reported fewer anxiety symptoms, particularly among individuals with pre-existing anxiety disorders. Another study with 60 anxious patients noted similar benefits lasting up to a week after the final dose. In a separate trial involving 70 anxiety patients, Selank augmented the effects of phenazepam (an anti-anxiety medication banned in some U.S. states) while reportedly minimizing side effects like drowsiness and memory impairment.

Animal studies have shown Selank's ability to reduce anxiety in mice, with more anxious subjects exhibiting notable behavioral improvements following treatment. Its effects were also observed in rats treated daily for four weeks.

While evidence remains limited, it suggests that Selank may help alleviate anxiety. Those experiencing anxiety should consult their doctor about the potential benefits of Selank, keeping in mind that it should not replace prescribed treatments.

In a 30-day study, Selank reportedly stabilized memory traces (potentially enhancing memory retention) in rats, although specifics remain unclear, as memory traces are not easily identifiable in the brain. Another study indicated that Selank might aid memory preservation in monkeys.

Human studies are currently lacking, and there is no clear understanding of Selank's effects on healthy individuals. Its safety for such users, whether short- or long-term, remains uncertain, warranting caution until further research is conducted.

Research indicated that Selank normalized brain activity in rats with toxin-induced brain damage.

Selank has demonstrated the ability to alleviate depressive symptoms (measured via immobility in a forced swimming test) in mice, showing greater effectiveness at lower doses.

One preliminary animal study indicated that Selank injections led to increased antioxidant levels in the livers of stressed mice.

In a study involving sedated cats, Selank was found to reduce blood pressure by approximately 30% for up to three minutes while enhancing blood flow to the brain by around 24% for up to ten minutes. Although these initial findings suggest temporary cardiovascular effects, the short duration raises questions about their significance, and these observations were limited to animals, leaving its effects on healthy humans uncertain.

Anxiety can often accompany alcohol withdrawal. In a study simulating high alcohol intake, rats given a 10% ethanol solution for 24 weeks were found to experience reduced anxiety symptoms following a 48-hour withdrawal period when treated with Selank.

In another animal study, rats on a high-fat diet treated with Selank showed 35% less weight gain, along with significant reductions in total cholesterol levels (over 58%) and blood glucose levels (23.5%).

A study involving breast cancer-affected mice found that those receiving daily doses of Selank exhibited slower tumor growth and longer lifespans compared to untreated mice. However, this finding does not imply any anticancer efficacy of Selank, and more extensive research is needed before considering it a viable cancer treatment option.

Post-treatment with Selank, increases in levels of several inflammatory response genes were observed in the spleens of mice, indicating potential protective benefits against inflammation.

Selank has been shown to decrease the area of stomach ulcers in animal models, possibly by enhancing lymph flow to the stomach, which is crucial for immune function. However, comprehensive human studies are required to confirm these effects and their underlying mechanisms.

Selank was reported to increase IL-6 levels in blood cells from patients with depression. IL-6 is an inflammatory protein that may assist in combating infections. Moreover, in one cell-based study, Selank stimulated the release of interferons, molecules that target viruses.

While some evidence suggests that Selank could protect cells from certain viral infections, results from an animal study with virus-infected mice have raised questions about these antiviral benefits. Further research is crucial to fully evaluate Selank's potential and limitations.